GE HealthCare Technologies Inc. reaffirmed earnings guidance for the full year 2024. For the year, the company expected organic revenue growth of approximately 4% year-over-year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78 USD | -1.03% |
|
-0.34% | +0.88% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.88% | 35.6B | |
+5.16% | 213B | |
+9.62% | 188B | |
+31.18% | 157B | |
+33.37% | 113B | |
+3.46% | 64.85B | |
+1.51% | 49.1B | |
-4.27% | 38.83B | |
+8.44% | 27.4B | |
+18.01% | 23.97B |
- Stock Market
- Equities
- GEHC Stock
- News GE HealthCare Technologies Inc.
- GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024